Yoon Hee Choi

Osimertinib for Patients With Non–Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Multicenter, Open-Label, Phase II Trial (KCSG-LU15-09)

Jang Ho Cho, Sung Hee Lim, Ho Jung An et al. · Journal of Clinical Oncology · 2019 · 346 citations · Full text

Tonsil-derived mesenchymal stromal cells: evaluation of biologic, immunologic and genetic factors for successful banking

Kyung‐Ha Ryu, Kyung‐Ah Cho, Hae Sang Park et al. · Cytotherapy · 2012 · 141 citations

Regenerative Medicine, Allergy, Immunology +6

Clinical outcomes and prognostic factors in patients with breast diffuse large B cell lymphoma; Consortium for Improving Survival of Lymphoma (CISL) study

Ho‐Young Yhim, Hye Jin Kang, Yoon Hee Choi et al. · BMC Cancer · 2010 · 80 citations · Full text

Phase I dose-finding study of sorafenib in combination with capecitabine and cisplatin as a first-line treatment in patients with advanced gastric cancer

Chul Kim, Jae‐Lyun Lee, Yoon Hee Choi et al. · Investigational New Drugs · 2010 · 58 citations

Dose-finding Study, Oncology, Gastrointestinal Oncology +9

Randomized Phase II Study of Axitinib versus Observation in Patients with Recurred or Metastatic Adenoid Cystic Carcinoma

Eun Joo Kang, Myung‐Ju Ahn, Chan-Young Ock et al. · Clinical Cancer Research · 2021 · 57 citations · Full text